Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease which has seen few improvements in treatments in more than 40 years.
Beat AML was announced yesterday by Vice President Biden, along with many new, Moonshot inspired initiatives across industry, non-profit and government.
AML is the most lethal of the blood cancers, which together are the third leading cause of cancer deaths in the U.S.; AML is responsible for more than 10,000 deaths each year. Despite advances in treating other blood cancers, the standard of treatment for AML – a combination of toxic chemotherapies – has remained the same for more than 40 years. Overall prognosis remains poor, with a five-year survival rate below 20 percent for patients over age 60.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554854-lls-beat-aml-acute-myeloid-leukemia/
Early findings from a major research initiative of the Crohn’s & Colitis Foundation of America (CCFA) suggest that specific bacteria play a central role in Crohn’s disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD). The evidence raises the possibility of developing new treatments to target the gut microbiome—the “ecosystem” of microbes populating the intestines—linked to the development of IBD.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7204351-crohn-s-colitis-foundation-of-america-gut-bacteria-new-strategies-to-prevent/
Actresses Shay Mitchell and Nina Dobrev are giving back this holiday season by starring in a month-long global philanthropic advertising campaign powered by IPG Mediabrands in support of Free The Children’s WE Are Stronger Together campaign. With the purchase of a $10 Rafiki bracelet, handmade with love by women in Kenya, a gift of impact is unlocked – water, healthcare, school supplies, healthy meals – helping to break the cycle of poverty and create a brighter future for Free The Children partner communities in Kenya, India, Ecuador, Haiti, Sierra Leone, Tanzania, Nicaragua and rural China.
By wearing a Rafiki bracelet, available at we.org and select retail stores including Walgreens, PacSun and Nordstrom, North Americans have the opportunity to join Shay Mitchell and Nina Dobrev in making a statement that they are part of the WE movement – a generation who believes that together WE can change the world. Each Rafiki purchased has a unique code for consumers to enter online at trackyourimpact.com so they can track exactly in what Free The Children community a life-changing gift was given.
To view the multimedia release go to:
http://www.multivu.com/players/English/7722251-free-the-children-we-are-stronger-together/
Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial) diarrhoea in industrialised countries.2 In a report launched today, during a meeting hosted by the European Healthcare and Hospital Federation (HOPE), experts from across Europe highlight the current deficiencies in the management of CDI and outline the steps that are needed to address them.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60637-astellas-report-diagnosis-management-CDI
Don’t trust us, trust Science: Abbott is among the best science-based companies to work for in the world.
For the 13th consecutive year, the journal Science today recognized Abbott on its Top Employers list, evaluated on 23 characteristics including financial strength, easy adaptation to change and a having a research-driven environment.
”Abbott is unique in that we’ve been adding to our reservoir of scientific knowledge for 128 years,“ said John Frels, Ph.D., chair of Abbott’s Scientific Governing Board, which oversees the company’s senior scientific career track. ”We strive to bring in the best and brightest scientists and engineers to work on some of the biggest problems in healthcare today. This helps us to create new, breakthrough innovations that change people’s lives.“
To view the multimedia release go to:
http://www.multivu.com/players/English/7962251-science-names-abbott-2016-top-employer/
Dornier MedTech® America, a global medical device company and the pioneer of Extracorporeal Shock Wave Lithotripsy (ESWL®), has received FDA clearance to market the Delta® III. This is the latest generation of the world’s best-selling and most clinically cited lithotripter, the Delta II.
To view the multimedia release go to:
https://www.multivu.com/players/English/8134451-dornier-medtech-delta-iii-kidney-stone-lithotripter/
Cigna (NYSE: CI) today unveiled its new TV Doctors of America campaign to encourage people to improve their health by going for their annual check-up, knowing their biometric numbers for blood pressure, cholesterol, blood sugar and body mass index (BMI), and taking control of their health. Supporting Cigna’s effort are actors Patrick Dempsey, Donald Faison, Neil Patrick Harris and Kate Walsh. All four actors starred as doctors on TV and are striking doctor poses, donning scrubs and using their celebrity influence to shine a spotlight on preventive care and the importance of going to a real doctor for an annual check-up that can help save lives.
To view the multimedia release go to:
https://www.multivu.com/players/English/8163851-cigna-americas-tv-doctors-go-know-take-control/
CPhI Worldwide, part of UBM Live’s Pharmaceutical Portfolio, today celebrates its 25th birthday by releasing the first in a series of ‘made at CPhI’ pharma stories. These will follow 25 pharma industry successes that have directly resulted from meetings at CPhI. The first story charts Global Pharmaceutical Relief from a first meeting at CPhI only two years ago to today and providing hundreds of millions of dollars worth of medicines to the developing world via NGOs- not just another business story, but a great example of the CPhI family helping to proliferate healthcare throughout the globe.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762554-cphi-worldwide-celebrates-25-years/
Bayer Healthcare, the makers of Coppertone®, kicked off an exciting multi-year deal with U.S. Soccer and the National Women’s Soccer League to encourage the use of sun protection on and off the field and help soccer fans across the country enjoy every minute of the game. Christen Press, star forward for the U.S. Women’s National Team, will be joined by fellow soccer stars Graham Zusi, Kelley O’Hara, and Matt Besler as brand ambassadors for Coppertone.
“I’m so excited to be a Coppertone brand ambassador because as an athlete, taking care of my body is a huge part of my job and sunscreen is a vital part of that,” said Press. “Whether I’m running up and down the field or running errands, I make it a point to ensure that my skin is protected. Everyone, especially athletes and fans everywhere, need to make sunscreen and sun protection a priority.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7325851-bayer-coppertone-women-s-soccer-sun/
Results from a new national survey released today indicate that our lifestyle exacerbates the challenge of trying to lose weight, making it more difficult than ever for adults to do so. Findings further suggest that adults who are trying to lose weight need a new approach that’s compatible with how we live today.
Specifically, most healthcare professionals and a majority of U.S. adults say losing weight is harder today than it was for previous generations because of the busy, modern lifestyle of Americans (77% of primary care physicians or PCPs, 81% of pharmacists, 62% U.S. adults). In fact, approximately seven in 10 healthcare professionals say it’s harder for Americans today to lose weight compared to just 10 years ago (69% of PCPs, 73% of pharmacists), and the vast majority believe Americans need to take a new approach to weight loss that fits with today’s modern lifestyle (89% of PCPs, 95% of pharmacists).
To view the multimedia release go to:
https://www.multivu.com/players/English/8215151-the-truth-about-weight-loss-national-survey/
An estimated 48 million people in the United States have hearing loss, yet only 20 percent of people who could benefit from a hearing aid wear one. Cost is a major barrier as the average price of a hearing aid is $1,500 per ear, and can run as high as $3,000-$5,000 each. With the introduction of HearTEK™ Leasing from EPIC Hearing Healthcare (EPIC), individuals with hearing loss now have access to the latest name brand hearing aid technology without the barrier of huge upfront costs and with the peace of mind that they will not be locked into out-of-date technology.
“Consumers have gotten used to many of the benefits of leasing their smartphones – no one wants to pay upfront for technology that could be quickly outdated as hearing aid manufacturers regularly introduce new devices with updated features,” said Brad Volkmer, president and CEO, EPIC Hearing Healthcare. “The HearTEK Leasing program is an affordable new way to give more people with hearing loss access to quality hearing aid technology, so they can start hearing life to the fullest.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7808551-epic-heartek-leasing-hearing-aid/
New science in molecular and genetic testing for breast, colon, and prostate cancer, as well as leukemia, will be among the special features at the College of American Pathologists’ annual scientific and education meeting, CAP’14—THE Pathologists’ Meeting, Sept. 7-10 at the Hyatt Regency in Chicago.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7270051-college-of-american-pathologists-cap-14-what-s-next-in-cancer-testing/
